Generational Trends and Innovations in Retinal Disease Care

Author(s):

Key Takeaways

The Ang/Tie pathway is a promising target for novel cancer therapies, highlighting its potential in treatment strategies.
Re-evaluation of steroid use in oncology may impact patient management and treatment outcomes.
Biosimilars are increasingly recognized as cost-effective alternatives, influencing the economic landscape of cancer treatment.
Emerging therapies in the pipeline suggest a dynamic and innovative future for oncology, with potential to transform current treatment paradigms.

A panel of ophthalmologists discuss how retinal disease management has evolved in the past decade and continues to change with advancements in diagnostics and therapies.

To watch the video series component of this episode, click here.

1:00 Evolving trends

5:50 Key Advances

8:20 Targeting Ang/Tie pathway

13:12 Role of steroids

15:00 Biosimilars

18:44 Therapies in the pipeline